Aims To develop and validate patient-centred algorithms that estimate individual risk of death over the first year after elective joint arthroplasty surgery for osteoarthritis. Methods A total of 763,213 hip and knee joint arthroplasty episodes recorded in the National Joint Registry for England and Wales (NJR) and 105,407 episodes from the Norwegian Arthroplasty Register were used to model individual mortality risk over the first year after surgery using flexible parametric survival regression. Results The one-year mortality rates in the NJR were 10.8 and 8.9 per 1,000 patient-years after hip and knee arthroplasty, respectively. The Norwegian mortality rates were 9.1 and 6.0 per 1,000 patient-years, respectively. The strongest predictors...
BACKGROUND: We aimed to measure the period effect (change over time) in 30-day mortality after total...
Objectives The ability to efficiently and accurately predict future risk of primary total hip and kn...
Objective: To evaluate the 90 days and 1 year mortality predictive ability of the RxRisk-V, Charlson...
Aims To develop and validate patient-centred algorithms that estimate individual risk of death over...
Aims To develop and validate patient-centred algorithms that estimate individual risk of death ov...
Objective Total knee replacement (TKR) is the most effective intervention available for the treatme...
Purpose: The purpose of this study was to develop and validate a prediction model for 90-day mortali...
Objective: To develop a user-friendly prediction tool of one-year mortality for patients with hip fr...
INTRODUCTION: Patients with total hip arthroplasty (THA) due to osteoarthritis (OA) are usually heal...
Objective. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are effective procedures f...
Introduction: THR / TKR surgery are effective procedures for patients with moderate-to-severe osteoa...
Background The lengthening of life expectancy and improvements in surgical techniques have resulted ...
BACKGROUND: Understanding the risk factors for early death after knee replacement could help to redu...
We report the general mortality rate after total knee replacement and identify independent predictor...
Background Elective total knee replacement (TKR) is a safe and cost-effective surgical procedure for...
BACKGROUND: We aimed to measure the period effect (change over time) in 30-day mortality after total...
Objectives The ability to efficiently and accurately predict future risk of primary total hip and kn...
Objective: To evaluate the 90 days and 1 year mortality predictive ability of the RxRisk-V, Charlson...
Aims To develop and validate patient-centred algorithms that estimate individual risk of death over...
Aims To develop and validate patient-centred algorithms that estimate individual risk of death ov...
Objective Total knee replacement (TKR) is the most effective intervention available for the treatme...
Purpose: The purpose of this study was to develop and validate a prediction model for 90-day mortali...
Objective: To develop a user-friendly prediction tool of one-year mortality for patients with hip fr...
INTRODUCTION: Patients with total hip arthroplasty (THA) due to osteoarthritis (OA) are usually heal...
Objective. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are effective procedures f...
Introduction: THR / TKR surgery are effective procedures for patients with moderate-to-severe osteoa...
Background The lengthening of life expectancy and improvements in surgical techniques have resulted ...
BACKGROUND: Understanding the risk factors for early death after knee replacement could help to redu...
We report the general mortality rate after total knee replacement and identify independent predictor...
Background Elective total knee replacement (TKR) is a safe and cost-effective surgical procedure for...
BACKGROUND: We aimed to measure the period effect (change over time) in 30-day mortality after total...
Objectives The ability to efficiently and accurately predict future risk of primary total hip and kn...
Objective: To evaluate the 90 days and 1 year mortality predictive ability of the RxRisk-V, Charlson...